Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nonmyeloablative Allogeneic Stem Cell Transplant for the Treatment of Hematologic Disorders

NCT00636909 is registered in ClinicalTrials.gov with Beth Israel Deaconess Medical Center as lead sponsor.

NCT NCT00636909
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00636909 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nonmyeloablative Allogeneic Stem Cell Transplant for the Treatment of Hematologic Disorders
Lead sponsor
Beth Israel Deaconess Medical Center
Phase
Phase 2
Overall status
Completed
Start date
July 31, 1999
Completion date
Not reported
Enrollment
25 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

all, aml, aplastic anemia, cll, cml chronic phase, accelerated phase, or blast crisis, mds, multiple myeloma, myeloproliferative disorder (p vera, cmml, et), relapsed non-hodgkin's or hodgkin's lymphoma